See also this year's filing and all EDGAR filings for this company.
PDF Report 0001771910_2024_ADC_Therapeutics_SA.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001771910, ADC Therapeutics SA
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 336,291,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 5,622,000 |
| 3 | remainder_Assets | 12,869,000 |
| 4 | LiabilitiesCurrent | 67,670,000 |
| 5 | LiabilitiesNoncurrent | 19,059,000 |
| 6 | remainder_Liabilities | 416,302,000 |
| 7 | CostOfGoodsAndServicesSold | 2,529,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 48,424,000 |
| 9 | ResearchAndDevelopmentExpense | 127,127,000 |
| 10 | remainder_Expenses | 96,570,000 |
| 11 | remainder_Revenues | 69,558,000 |
| 12 | remainder_NetIncome | -34,961,000 |
| 13 | remainder_ComprehensiveNetIncome | -1,916,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 354,782,000 |
| 1 | Liabilities | 503,031,000 |
| 2 | Expenses | 274,650,000 |
| 3 | Revenues | 69,558,000 |
| 4 | StockholdersEquity | -148,249,000 |
| 5 | NetIncome | -240,053,000 |
| 6 | ComprehensiveNetIncome | -241,011,000 |
| 7 | BaseVar | 619,449,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -1.32 |
| 9 | EconomicCapitalRatio | 1.23 |
Edgar->Model Mapping
Feature Distribution
